Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)
Open Access
- 10 January 1994
- journal article
- Published by Wiley in FEBS Letters
- Vol. 337 (2) , 131-134
- https://doi.org/10.1016/0014-5793(94)80259-9
Abstract
A recombinant soluble human urokinase receptor comprising amino acids 1–277 was cloned and transfected into CHO cells. The mutant protein (rec‐uPAR277), purified from the CHO cell supernatant by affinity chromatography on immobilized urokinase (uPA), in a four‐fold excess, completely abolished the binding of FITC‐labeled pro‐uPA to the human ovarian cancer cell line, OV‐MZ‐6. This invasive and tumorigenic cancer cell line expresses uPA, its inhibitor PAI‐1, and the high‐affinity receptor for uPA, uPAR. Rec‐uPAR277 significantly reduced the proliferation of OV‐MZ‐6 cells in a concentration‐dependent manner without altering the viability of the cells. Invasion of OV‐MZ‐6 cells tested in an in vitro Matrigel invasion assay was inhibited by rec‐uPAR277 up to 75%. In conclusion, these results demonstrate that rec‐uPAR277 can function as a scavenger for uPA in vitro by inhibiting proliferation and invasion of human cancer cells.Keywords
This publication has 16 references indexed in Scilit:
- UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA), A PROTEASE WITH CYTOKINE-LIKE ACTIVITY IN HUMAN HL-60 LEUKEMIC-CELL LINEInternational Journal of Oncology, 1993
- Prevention of metastasis by inhibition of the urokinase receptor.Proceedings of the National Academy of Sciences, 1993
- Interaction of urokinase‐type plasminogenactivator (u‐PA) with its cellular receptor (u‐PAR) induces phosphorylation on tyrosine of a 38 kDa proteinFEBS Letters, 1993
- Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell linesInternational Journal of Cancer, 1992
- Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cellsExperimental Cell Research, 1991
- Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.Proceedings of the National Academy of Sciences, 1989
- Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzymeEuropean Journal of Biochemistry, 1989
- Autocrine saturation of pro-urokinase receptors on human A431 cellsCell, 1986
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985
- Antibodies to plasminogen activator inhibit human tumor metastasisCell, 1983